
    
      This is an open-label, single-centre study to evaluate the pharmacokinetics of single-dose
      digoxin alone and when administered at various up titration doses of ezogabine/retigabine in
      healthy adult subjects. The pharmacokinetics of ezogabine/retigabine and the n-acetyl
      metabolite of ezogabine/retigabine (NAMR) will also be assessed.
    
  